Reported results
- GAAP net sales were $58.0 million for the third quarter of 2026, compared to $49.1 million for the same period in 2025.
- GAAP net income was $3.4 million, or $0.80 per diluted share, for the third quarter of 2026, compared to $1.9 million, or $0.46 per diluted share, for the same period in 2025.
- GAAP gross margin was 45.3% in the third quarter of 2026 versus 39.1% in the comparable period last year.
- GAAP net sales for the nine months ended September 30, 2026, were $173.0 million, compared to $149.0 million in the same period in 2025.
- GAAP net income for the nine months ended September 30, 2026, was $9.5 million, or $2.29 per diluted share, compared to $8.3 million, or $2.03 per diluted share, for the same period in 2025.
Guidance
- The annual savings from the DMT plant closure are expected to be more than $1.0 million in 2027.
Notes
The Company recognized $4.0 million of an IEEPA tariff refund as a reduction of cost of goods sold in the third quarter of 2026 and recorded $1.0 million of variable compensation expense related to the refund; cost of goods sold also included $1.8 million of costs accrued in connection with the close of the DMT sharpening facility.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.
